Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Abzena has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.
read more
Sterling Pharma Solutions has signed an agreement with Moleculin Biotech to support the company’s expanded development efforts for its potential COVID-19 treatment, WP1122.
read more
La Loma, Tlalnepantla, Mexico, Real Clean Distribuciones SA de CV is voluntarily recalling all lots four hand sanitizers it manufactured.
read more
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Exonbio has launched the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
Protalix BioTherapeutics has entered into a non-binding term sheet with SarcoMed USA Inc.
read more
JanOne has received confirmation from the FDA for the IND sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience.
read more
The Menarini Group and Radius Health announced the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.
read more
MediciNova announced an agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine using BC-PIV, a human parainfluenza virus type 2 vector.
read more
Novavax and FUJIFILM Diosynth Biotechnologies has announced an agreement to manufacture bulk drug substance for NVX-CoV2373, Novavax' COVID-19 vaccine candidate.
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
To reduce the risk of death from opioid overdose, the FDA is making the following recommendations about the opioid reversal medicine, naloxone.
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
SP Industries CEO Brian Larkin has announced the signing of a partnership agreement with Ecodyst.
read more